EL
EL
Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.
Insider Buys
0
$0
Insider Sales
0
$0
Total Volume
$0
19 transactions
Net Activity
+$0
Net buying
Sentiment Rating
Neutral / BalancedCEO Conviction Index
No Recent Signal
Key Drivers
- •Balanced trading volume with net neutral buying and selling activity.
Score Methodology
The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:
- +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
- +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
- +15CEO Buying: CEO committing own capital shows high conviction.
- +10CFO Buying: CFO purchasing shares shows financial alignment.
EL has an insider buy conviction of 50%, compared to the Unknown sector buy average of 50%.
Multiple Insiders
S - Sale Insiders
$0 total
Over the last 90 days, corporate insiders at EL (EL) engaged in a total of 19 transactions reported via SEC Form 4 filings. Among these, 0 were open-market purchases and 0 were sales. The total volume of insider trading reached $0.
The net insider activity for EL shows a net buying bias of $0. This activity represents a 50% buy ratio, suggesting that insiders are currently neutral on the company's near-term outlook relative to recent history.
The most notable individual transaction was a Sale by Multiple Insiders (S - Sale Insiders), who traded 421.3K shares valued at $0 on Sep 11, 2026.
Quick Actions
Related News & Analyst Reports
Read original insights and educational research covering EL and the Unknown sector.
The Biotech Executive Playbook: Tracking Clinical Phase SEC Filings
An empirical study on how clinical-stage biotech executives execute Form 4 open-market purchases ahead of trial data releases, outlining the regulatory gaps and alpha potential of clinical insider tracking.
Spotting Insider Sells: When to Worry and When to Ignore
Most insider sales are irrelevant, estate planning, tax obligations, diversification. But certain Form 4 selling patterns are genuine red flags. This guide teaches you exactly when to worry: cluster sells, CEO departures, and pre-restatement patterns.
The Y Combinator Spinoff Trade: Spotting Alpha in Post-Demo Day IPOs
Y Combinator alumni companies show distinctive insider liquidity patterns after IPO. This report maps Form 4 activity at YC-backed public companies to identify when founder and early-investor selling subsides and conviction buying begins.
Y Combinator Alum Stock Performance Post-IPO: The SEC Form 4 Perspective
A systematic review of SEC Form 4 activity at YC alumni companies post-IPO, tracking when founders shift from selling to buying, how early investor lock-up expiration affects price, and which YC cohort vintages show the strongest insider conviction signals.
Sequoia Capital and the Mechanics of Venture Lock-Up Extensions
Sequoia Capital pioneered the use of voluntary lock-up extensions to signal portfolio company confidence. This report analyzes the market-price impact of Sequoia extension announcements and whether they have historically justified the delay.
Unusual Insider Buying Patterns: Spotting the Anomalies
Beyond simple purchase screens, unusual insider buying patterns, accelerating purchase velocity, off-hours filings, purchases during active 10b5-1 plans, can reveal extraordinary conviction. This guide documents nine pattern types and their historical signal accuracy.
FAQs About EL Insider Trading
Answers to common questions regarding corporate filings and executive sentiment for EL.